Co-Diagnostics Current Ratio 2017-2025 | CODX
Co-Diagnostics current ratio from 2017 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Co-Diagnostics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.02B | $0.01B | 4.43 |
| 2024-12-31 | $0.03B | $0.01B | 4.41 |
| 2024-09-30 | $0.04B | $0.01B | 6.92 |
| 2024-06-30 | $0.05B | $0.01B | 9.09 |
| 2024-03-31 | $0.05B | $0.01B | 10.19 |
| 2023-12-31 | $0.06B | $0.01B | 10.81 |
| 2023-09-30 | $0.07B | $0.01B | 13.99 |
| 2023-06-30 | $0.08B | $0.01B | 15.13 |
| 2023-03-31 | $0.09B | $0.00B | 23.80 |
| 2022-12-31 | $0.09B | $0.00B | 23.94 |
| 2022-09-30 | $0.10B | $0.01B | 16.95 |
| 2022-06-30 | $0.12B | $0.01B | 17.06 |
| 2022-03-31 | $0.13B | $0.01B | 9.63 |
| 2021-12-31 | $0.12B | $0.01B | 9.14 |
| 2021-09-30 | $0.10B | $0.00B | 24.83 |
| 2021-06-30 | $0.09B | $0.01B | 19.10 |
| 2021-03-31 | $0.08B | $0.00B | 18.38 |
| 2020-12-31 | $0.07B | $0.00B | 16.69 |
| 2020-09-30 | $0.05B | $0.00B | 28.63 |
| 2020-06-30 | $0.04B | $0.00B | 12.36 |
| 2020-03-31 | $0.02B | $0.00B | 16.43 |
| 2019-12-31 | $0.00B | $0.00B | 4.83 |
| 2019-09-30 | $0.00B | $0.00B | 10.02 |
| 2019-06-30 | $0.01B | $0.00B | 14.61 |
| 2019-03-31 | $0.01B | $0.00B | 16.53 |
| 2018-12-31 | $0.00B | $0.00B | 0.45 |
| 2018-09-30 | $0.00B | $0.00B | 1.09 |
| 2018-06-30 | $0.00B | $0.00B | 6.13 |
| 2018-03-31 | $0.00B | $0.00B | 10.98 |
| 2017-12-31 | $0.00B | $0.00B | 7.09 |
| 2017-09-30 | $0.01B | $0.00B | 8.73 |
| 2017-06-30 | $0.00B | $0.01B | 0.07 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.010B | $0.004B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.314B | 25.57 |
| Elevance Health (ELV) | United States | $85.975B | 11.09 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.343B | 19.60 |
| DiDi Global (DIDIY) | China | $22.968B | 34.86 |
| Natera (NTRA) | United States | $21.581B | 0.00 |
| BioMerieux (BMXMF) | France | $15.705B | 0.00 |
| Solventum (SOLV) | United States | $12.562B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.357B | 0.00 |
| CochLear (CHEOY) | Australia | $11.324B | 0.00 |
| Revvity (RVTY) | United States | $10.833B | 18.64 |
| ICON (ICLR) | Ireland | $10.585B | 9.84 |
| Viatris (VTRS) | United States | $10.364B | 3.56 |
| Doximity (DOCS) | United States | $9.697B | 45.17 |
| Avantor (AVTR) | United States | $8.886B | 12.91 |
| HealthEquity (HQY) | United States | $8.734B | 42.97 |
| Medpace Holdings (MEDP) | United States | $8.538B | 22.68 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.763B | 13.25 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.142B | 24.42 |
| BrightSpring Health Services (BTSG) | United States | $4.077B | 37.74 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Concentras Parent (CON) | United States | $2.767B | 15.99 |
| Organon (OGN) | United States | $2.480B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.103B | 8.96 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.90 |
| Premier (PINC) | United States | $1.891B | 14.36 |
| Progyny (PGNY) | United States | $1.829B | 40.26 |
| PACS (PACS) | United States | $1.513B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.361B | 27.21 |
| Teladoc Health (TDOC) | United States | $1.225B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.30 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.003B | 0.00 | |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| CareDx (CDNA) | United States | $0.922B | 14.40 |
| Nutex Health (NUTX) | United States | $0.921B | 13.91 |
| AMN Healthcare Services Inc (AMN) | United States | $0.807B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.523B | 43.04 |
| LifeMD (LFMD) | United States | $0.522B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.387B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.224B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| KindlyMD (NAKA) | United States | $0.135B | 0.00 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.093B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.069B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |